losartan has been researched along with nitrites in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 11 (57.89) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cachofeiro, V; Lahera, V; Maeso, R; Muñoz-García, R; Navarro-Cid, J; Rodrigo, E; Ruilope, LM | 1 |
| Manucha, WA; Valles, PG | 1 |
| Juncos, LA; Manriquez, MC; Ortiz, MC; Romero, JC; Sanabria, E | 1 |
| Basso, N; González Bosc, LV; Kurnjek, ML; Müller, A; Terragno, NA | 1 |
| Johnson, RJ; Kang, DH; Mazzali, M; Ray, PE; Suga, S | 1 |
| Fukuyama, R; Fushiki, S; Harada, S; Hatta, T; Kido, H; Nakata, T; Oguni, A; Sasaki, S; Takeda, K | 1 |
| Duarte, J; Moreno, JM; Osuna, A; Rodríguez-Gómez, I; Sainz, J; Vargas, F; Wangensteen, R | 1 |
| Berti, F; Bianchi, M; Bonomo, S; De Gennaro Colonna, V; Ferrario, P; Fioretti, S; Manfredi, B; Muller, EE; Rigamonti, A; Rossoni, G | 1 |
| Ahmad, M; Al-Shabanah, OA; Khattab, M; Raza, M | 1 |
| Berti, F; Bonomo, S; De Gennaro Colonna, V; Fioretti, S; Manfredi, B; Muller, EE; Rigamonti, A; Rossoni, G | 1 |
| Chen, MF; Li, YJ; Luo, BL; Wang, YJ; Xie, XM; Yang, TL; Zhang, XH | 1 |
| Furuta, K; Hongo, M; Ishizaka, N; Koike, K; Matsuzaki, G; Nagai, R; Saito, K; Sakurai, R | 1 |
| de Faria, JB; de Faria, JM; Rosales, MA; Silva, KC | 1 |
| Budhiraja, RD; Sharma, S; Tyagi, S | 1 |
| Ashrafi, F; Baradaran-Mahdavi, MM; Eshraghi, F; Hashemi-Nia, SJ; Jafapisheh, A; Khazaei, M; Mortazavi, M; Nasri, H; Nematbakhsh, M; Olia, B; Pezeshki, Z; Pirhaji, O; Safari, T; Talebi, A | 1 |
| Abdel Meguid, E; El Sarha, A; Gowayed, M; Refaat, R; Salama, M | 1 |
| Cai, Z; Gu, M; Guo, J; Li, WJ; Wang, Z; Xu, M; Zheng, DC | 1 |
| Abd-Eldayem, AM; Abdel-Zaher, AO; El-Refaiy, AEM; Farghaly, HSM | 1 |
| Casarini, DE; Ceron, CS; Fernandes, FB; Guimaraes, DA; Martins-Oliveira, A; Oliveira, DMM; Pinheiro, LC; Rizzi, E; Tanus-Santos, JE; Tirapelli, CR | 1 |
19 other study(ies) available for losartan and nitrites
| Article | Year |
|---|---|
Factors involved in the effects of losartan on endothelial dysfunction induced by aging in SHR.
Topics: Acetylcholine; Aging; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Kidney; Losartan; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitrites; Phenylephrine; Potassium Chloride; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Vasoconstrictor Agents; Vasodilation | 1998 |
H+-ATPase activity on unilateral ureteral obstruction: interaction of endogenous nitric oxide and angiotensin II.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Enzyme Activation; Enzyme Inhibitors; Female; Kidney Medulla; Losartan; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Proton-Translocating ATPases; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation; Ureteral Obstruction | 2000 |
Role of endothelin and isoprostanes in slow pressor responses to angiotensin II.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Bosentan; Endothelins; Glomerular Filtration Rate; Infusions, Intravenous; Losartan; Nitrites; Prostaglandins; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sulfonamides | 2001 |
Effect of chronic angiotensin II inhibition on the nitric oxide synthase in the normal rat during aging.
Topics: Aging; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cardiomegaly; Enalapril; Losartan; Male; NADPH Dehydrogenase; Nitrates; Nitric Oxide Synthase; Nitrites; Rats; Rats, Wistar; Reference Values; Time Factors | 2001 |
Angiotensin II type 1 receptor blockade ameliorates tubulointerstitial injury induced by chronic potassium deficiency.
Topics: Angiotensin Receptor Antagonists; Animals; Arginine; Chronic Disease; Dinoprostone; Kidney; Losartan; Male; Nitrates; Nitrites; Potassium Deficiency; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1 | 2002 |
Contrasting effects of angiotensin type 1 and 2 receptors on nitric oxide release under pressure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Apoptosis; Bradykinin; Cell Count; Cells, Cultured; Endothelium, Vascular; Gene Expression; Glyceraldehyde-3-Phosphate Dehydrogenases; In Vitro Techniques; Losartan; Male; Nitrates; Nitric Oxide; Nitrites; Oxygen; Pressure; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin | 2002 |
Increased pressor sensitivity to chronic nitric oxide deficiency in hyperthyroid rats.
Topics: Angiotensin II; Animals; Blood Pressure; Creatinine; Enzyme Inhibitors; Heart Rate; Hyperthyroidism; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Potassium; Proteinuria; Rats; Rats, Wistar; Sodium; Thyroxine | 2003 |
Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
Topics: 6-Ketoprostaglandin F1 alpha; Acetylcholine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Enalapril; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; In Vitro Techniques; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitrites; Norepinephrine; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Systole; Vasoconstriction; Vasodilation; Vasodilator Agents | 2005 |
Effects of losartan on blood pressure, oxidative stress, and nitrate/nitrite levels in the nitric oxide deficient hypertensive rats.
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Body Weight; Creatinine; Dose-Response Relationship, Drug; Heart; Hypertension; Kidney; Lipid Peroxidation; Losartan; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitrites; Organ Size; Oxidative Stress; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Time Factors | 2004 |
Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism.
Topics: 6-Ketoprostaglandin F1 alpha; Acetylcholine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin B2 Receptor Antagonists; Endothelium, Vascular; Gene Expression Regulation, Enzymologic; Hypertension; Kinins; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase Type III; Nitrites; Nitroprusside; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Bradykinin B2; RNA, Messenger; Vasodilation | 2006 |
Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II.
Topics: Amidohydrolases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arginine; Cell Adhesion; Cells, Cultured; Culture Media, Conditioned; Endothelial Cells; Endothelium, Vascular; Gene Expression Regulation; Humans; Interleukin-8; Losartan; Monocytes; NF-kappa B; Nitrates; Nitric Oxide; Nitrites; Protein-Arginine N-Methyltransferases; Reactive Oxygen Species; Receptors, Interleukin-8B; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Umbilical Veins; Vasculitis; Vasodilation | 2007 |
Comparison of vasculoprotective effects of benidipine and losartan in a rat model of metabolic syndrome.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta, Thoracic; Calcium Channel Blockers; Dihydropyridines; Endothelium, Vascular; Fibrosis; Heart; In Vitro Techniques; Losartan; Metabolic Syndrome; Muscle Relaxation; Myocardium; Nitrates; Nitrites; Rats; Rats, Inbred OLETF; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2008 |
Reduction of inducible nitric oxide synthase via angiotensin receptor blocker prevents the oxidative retinal damage in diabetic hypertensive rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Deoxyguanosine; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Down-Regulation; Losartan; Male; Nitrates; Nitric Oxide Synthase Type II; Nitrites; Osmolar Concentration; Oxidation-Reduction; Rats; Rats, Inbred SHR; Retina; Superoxide Dismutase; Tyrosine; Up-Regulation | 2010 |
Effect of phosphatidylinositol 3-kinase-γ inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Atorvastatin; Blood Pressure; Desoxycorticosterone; Endothelium, Vascular; Female; Glutathione; Heptanoic Acids; Hypertension; Losartan; Male; Nitrates; Nitrites; Phosphoinositide-3 Kinase Inhibitors; Pyrroles; Rats; Rats, Wistar; Thiazolidinediones | 2012 |
A combination of vitamin C and losartan for cisplatin-induced nephrotoxicity in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Ascorbic Acid; Biomarkers; Blood Proteins; Blood Urea Nitrogen; Cisplatin; Creatinine; Cytoprotection; Disease Models, Animal; Drug Therapy, Combination; Kidney; Kidney Diseases; Losartan; Male; Nitrites; Rats; Rats, Wistar; Time Factors; Weight Gain | 2012 |
Evaluation of the effect of losartan and methotrexate combined therapy in adjuvant-induced arthritis in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arthritis, Experimental; C-Reactive Protein; Drug Therapy, Combination; Hindlimb; Interleukin-1beta; Losartan; Male; Methotrexate; Nitrates; Nitrites; Rats; Rats, Sprague-Dawley; Serum Albumin; Transaminases; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2013 |
Losartan Preserves Erectile Function by Suppression of Apoptosis and Fibrosis of Corpus Cavernosum and Corporal Veno-Occlusive Dysfunction in Diabetic Rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Collagen; Cyclic GMP; Diabetes Mellitus, Experimental; Fibrosis; Losartan; Male; Muscle, Smooth; Nitrites; Penile Erection; Rats; Rats, Sprague-Dawley; Signal Transduction; Sildenafil Citrate; Smad Proteins; Transforming Growth Factor beta1 | 2017 |
Protective effect of the standardized extract of ginkgo biloba (EGb761) against hypertension with hypercholesterolemia-induced renal injury in rats: Insights in the underlying mechanisms.
Topics: Animals; Blood Pressure; Creatinine; Diastole; Ginkgo biloba; Glutathione; Hypercholesterolemia; Hypertension; Kidney; Lipids; Losartan; Male; Malondialdehyde; Nitric Oxide Synthase Type III; Nitrites; Plant Extracts; Protective Agents; Rats, Wistar; Simvastatin; Systole; Urea | 2017 |
Direct renin inhibition is not enough to prevent reactive oxygen species generation and vascular dysfunction in renovascular hypertension.
Topics: Amides; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta; Drug Synergism; Fumarates; Hypertension, Renovascular; Losartan; Male; Nitrites; Oxidative Stress; Rats; Reactive Oxygen Species; Relaxation; Renin | 2018 |